2nd Jun 2009 07:00
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
GW Pharmaceuticals |
2 Reason for the notification (please tick the appropriate box or boxes): |
||
An acquisition or disposal of voting rights |
X |
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|
An event changing the breakdown of voting rights |
|
|
Other (please specify): |
|
|
3. Full name of person(s) subject to the notification obligation: |
Prudential plc group of companies |
4. Full name of shareholder(s) (if different from 3.): |
See attached schedule |
5. Date of the transaction and date on which the threshold is crossed or reached: |
29 May 2009 |
6. Date on which issuer notified: |
01 June 2009 |
7. Threshold(s) that is/are crossed or reached: |
10% |
8. Notified details: |
|||||||
A: Voting rights attached to shares |
|||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
|||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
GB0030544687 |
12,070,000 |
12,070,000 |
13,070,000 |
13,070,000 |
|
10.82% |
|
|
B: Qualifying Financial Instruments |
||||
Resulting situation after the triggering transaction |
||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||
Resulting situation after the triggering transaction |
||||||
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights |
|
|
|
|
|
|
Nominal |
Delta |
|
|
Total (A+B+C) |
|
Number of voting rights |
Percentage of voting rights |
13,070,000 |
10.82% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
Prudential plc (parent Company) M&G Group Limited (wholly owned Subsidiary of Prudential plc) M&G Limited (wholly owned subsidiary of M&G Group Limited) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) M&G Securities Limited (wholly owned subsidiary of M&G Limited) |
Proxy Voting: |
|
10. Name of the proxy holder: |
N/A |
11. Number of voting rights proxy holder will cease to hold: |
N/A |
12. Date on which proxy holder will cease to hold voting rights: |
N/A |
13. Additional information: |
|
14. Contact name: |
Dipesh Varsani/ Mark Thomas M&G Investment Management Limited |
15. Contact telephone number: |
020 7548 3261 / 020 7548 3266 |
Notifiable Position Report for GW PHARMACEUTICALS ORD GBP0.001
as at 29 May 2009
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage holdings are calculated using an issued share capital of 120,785,335 ORD GBP0.001 shares
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Related Shares:
GWP.LPrudential